Editorial: Ovarian cancer targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more, volume II
Saved in:
Main Authors: | Zhi-Bin Wang, De-Hua Liao, Guang Lei, Zhao-Qian Liu, Nayiyuan Wu, Jing Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1552652/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PARP Inhibitors in the Treatment of Ovarian Cancer
by: Andrzej Paweł Zuzak, et al.
Published: (2025-02-01) -
Controversy About Management of Osteoarthritis with Disease-modifying Anti-rheumatic Drugs
by: CUI Hanshu, et al.
Published: (2025-01-01) -
Therapeutic anti-inflammatory immune potentials of some seaweeds extracts on chemically induced liver injury in mice
by: Eman Bases, et al.
Published: (2025-02-01) -
Impacts of National Reimbursement Drug Price Negotiation on drug accessibility, utilization, and cost in China: a systematic review
by: Zheng Zhu, et al.
Published: (2025-02-01) -
Simultaneous Determination of Multiple Acid-Suppressing Drugs by UPLC-MS/MS Method and Application for Pharmacokinetics Study
by: Li X, et al.
Published: (2025-02-01)